3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Malaria
1
Lymphoma, Follicular
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Intestinal Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Oxaliplatin
3
Irinotecan
3
Fluorouracil
3
Capecitabine
3
Bevacizumab
3
Leucovorin
2
Colonoscopy
2
Bisacodyl
2
Aspirin
2
lutetium Lu 177 dotatate
1
guadecitabine
1
copper dotatate CU-64
1
camrelizumab
1
apatinib
1
aldesleukin
1
XELOX
1
Ursodeoxycholic Acid
1
Trastuzumab
1
Suction
1
Simvastatin
1
Radiotherapy
1
Polyethylene Glycols
1
Oviposition
1
Lutetium-177
1
Lutetium
1
Ileostomy
1
Folfox protocol
1
Drainage
1
Cyclophosphamide
1
Chemoradiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Intestinal Neoplasms
×
Artesunate
×
Clear all
NCT02633098
2022-10-12
NeoART
St George's, University of London
Phase 2
Unknown
200 enrolled